Nexalin Technology (NXL) Share-based Compensation (2021 - 2026)
Nexalin Technology (NXL) posted Share-based Compensation of $4.1 million for Q2 2026, little changed on a QoQ basis from $4.1 million in Q1 2026, and up 35.4% year-over-year from $3.0 million in Q2 2025.
Analysis
Nexalin Technology (NXL) Share-based Compensation (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Share-based Compensation for 6 years, with the latest figure at $4.1 million in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 35.4% year-over-year to $4.1 million in Q2 2026; TTM through Jun 2026 was $4.1 million, a 35.4% increase from a year earlier, with the FY2025 full-year figure at $4.1 million, up 15.53% from the prior year.
- Share-based Compensation was $4.1 million for Q2 2026 at Nexalin Technology, roughly flat from $4.1 million in the prior quarter.
- The five-year high for Share-based Compensation was $4.1 million in Q1 2026, with the low at -$182049.0 in Q4 2022.
- Average Share-based Compensation over 5 years is $1.8 million, with a median of $1.9 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation sank 251.7% in 2022, then surged 166339.02% in 2024.
- Over 5 years, Share-based Compensation stood at -$182049.0 in 2022, then jumped by 1353.44% to $2.3 million in 2023, then sank by 32.0% to $1.6 million in 2024, then tumbled by 46.41% to $831529.0 in 2025, then soared by 394.71% to $4.1 million in 2026.
- The last three Share-based Compensation figures came in at $4.1 million (Q2 2026), $4.1 million (Q1 2026), and $831529.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | 4.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.11 Mn |
| Mar 31, 2026 | 4.11 Mn |
| Dec 31, 2025 | 831,529.00 |
| Sep 30, 2025 | 3.91 Mn |
| Jun 30, 2025 | 3.04 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 2.28 Mn |
| Mar 31, 2024 | 2.28 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 88,388.00 |
| Mar 31, 2023 | 1,371.00 |
| Dec 31, 2022 | -182,049.00 |
| Sep 30, 2022 | 184,291.00 |
| Jun 30, 2022 | 171,600.00 |
| Mar 31, 2022 | 97,500.00 |
| Dec 31, 2021 | 120,002.00 |
| Sep 30, 2021 | 1.49 Mn |